GDGillian Donachie

Gillian Donachie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gillian Donachie has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improved De Novo Peptide Binder Design with Target-Conditioned Inverse Folding

    by Elliot Layne, Ashlin K. Kanawaty, Aron Broom, Alexander Kitaygorodsky, Anita K. Nivedha, Parth Vora, Caroline Woffindale, Sarah Hailstone, Eirini Sachouli, Ella Halcrow, et al.

    Inverse protein folding methods have become central to the computational design of de novo proteins, but existing models struggle when tasked with generating high-affinity peptide binders. By combining peptide-specific finetuning with a novel decoding order strategy, we enhance pocket conditioning and enable more accurate sequence design for peptide-binding interfaces. Our approach delivers gains in computational metrics, increasing sequence recovery and improving in silico binder design success rate by 16% ™ 30%. In vitro validation finds that our method greatly improves the success rate of designing novel peptide agonists of the OPRM1 receptor, generating at least twice as many top-ranking agonists as the prevailing standard method ProteinMPNN.


  • Open Access

    Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma

    by Maisha F. Jabeen, Nicholas D. Sanderson, Mariaenrica Tinè, Gillian Donachie, Clair Barber, Adnan Azim, Laurie C. K. Lau, Thomas Brown, Ian D. Pavord, Anoop Chauhan, et al.

    Background: The airway microbiome in severe asthma has not been characterised at species‐level by metagenomic sequencing, nor have the relationships between specific species and mucosal immune responses in ‘type‐2 low’, neutrophilic asthma been defined. We performed an integrated species‐level metagenomic data with inflammatory mediators to characterise prevalence of dominant potentially pathogenic organisms and host immune responses.Methods: Sputum and nasal lavage samples were analysed using long‐read metagenomic sequencing with Nanopore and qPCR in two cross‐sectional adult severe asthma cohorts, Wessex (n = 66) and Oxford (n = 30). We integrated species‐level data with clinical parameters and 39 selected airway proteins measured by immunoassay and O‐link.Results: The sputum microbiome in health and mild asthma displayed comparable microbial diversity. By contrast, 23% (19/81) of severe asthma microbiomes were dominated by a single respiratory pathogen, namely H. influenzae (n = 10), M. catarrhalis (n = 4), S. pneumoniae (n = 4) and P. aeruginosa (n = 1). Neutrophilic asthma was associated with H. influenzae, M. catarrhalis, S. pneumoniae and T. whipplei with elevated type‐1 cytokines and proteases; eosinophilic asthma with higher M. catarrhalis, but lower H. influenzae, and S. pneumoniae abundance. H. influenzae load correlated with Eosinophil Cationic Protein, elastase and IL‐10. R. mucilaginosa associated positively with IL‐6 and negatively with FGF. Bayesian network analysis also revealed close and distinct relationships of H. influenzae and M. catarrhalis with type‐1 airway inflammation. The microbiomes and cytokine milieu were distinct between upper and lower airways.Conclusions: This species‐level integrated analysis reveals central, but distinct associations between potentially pathogenic bacteria and airways inflammation in severe asthma.